$BLCO news
The latest BLCO stock news: headlines, filings, AI summaries and sentiment for $BLCO, updated around the clock.
- Bausch + Lomb Reports Strong Q3 2026 Growth and Debt Reduction
- Bausch Health Projects 2026 Revenue Between $5.525B and $5.625B Amid Xifaxan Headwinds
- Bausch Health Reports Strong Q3 2026 Results with Record Adjusted EBITDA
- Bausch & Lomb Corp - 8-K Filing
- Bausch & Lomb Corp - 10-Q Filing
- Bausch Health Announces US$50 Million Share Repurchase Program
- Bausch + Lomb Reports Strong Q3 2026 Results with Growth Across All Business Segments
- Bausch & Lomb Corp - 8-K Filing
- Bausch + Lomb Scheduled to Report Q3 2026 Earnings on October 28
- Bausch & Lomb Corp - 8-K Filing
- Bausch + Lomb Names Thomas Appio as Interim CEO
- Bausch + Lomb Advances Development of Oral Treatment for Dry AMD
- Bausch + Lomb Reports Strong Q2 Results and Raises Full-Year Guidance
- Bausch + Lomb Provides Updated Revenue and EBITDA Guidance for 2026
- Bausch + Lomb Reports Mixed Q2 Results and Raises Revenue Guidance
- Bausch & Lomb Corp - 8-K Filing
- Bausch & Lomb Corp - 8-K Filing
- Bausch + Lomb Reports Q1 2026 Earnings with Revenue Growth and Strong Performance Across Segments
- Bausch Health Reports Q1 2026 Earnings with Revenue Growth and Margin Expansion
- Bausch + Lomb Announces Sustainability Milestone and Product Approvals
- Bausch Lomb Reports Q2 2025 Earnings with Revenue Growth and Segment Performance Details
- Bausch + Lomb (BLCO) Reports Q3 2025 Earnings with Revenue Growth
- Bausch + Lomb (BLCO) Reports Record Q4 2025 Earnings with Strong Revenue and EBITDA Growth